Source: DGNews  |  Posted 8 years ago

By Bruce Sylvester

ORLANDO, FL -- October 28, 2003 -- Radiographic evidence indicates that etanercept monotherapy slows joint damage in rheumatoid arthritis more than methotrexate monotherapy and that concurrent combination therapy with etanercept and methotrexate achieves significantly better efficacy results at 52 weeks when compared with either drug used alone, researchers reported here on October 25th at the Annual Meeting of the American College of Rheumatology (ACR).

"A large proportion of the combination therapy subjects achieved clinical remission, and we saw, for the first time, evidence of negative RA [rheumatoid arthritis] progression scores," said D